Product Description
Prescription Notice
Prescription-only medicine. Sold only against a valid prescription from a registered oncologist or medical practitioner. To be administered under medical supervision in a hospital or cancer-care setting.
Description
AB-Pacli 100 mg Injection contains Paclitaxel (100 mg per vial) as albumin-bound particles. It is a cytotoxic anti-cancer medicine belonging to the anti-microtubule agent group. Paclitaxel works by interfering with cell division, which stops certain cancer cells from growing. It is used in the treatment of cancers such as breast cancer, non-small cell lung cancer, ovarian cancer and AIDS-related Kaposi's sarcoma, as decided by the treating doctor. It is marketed by Adley Formulations and supplied as a single vial.
Specifications
Brand: AB-Pacli
Composition: Paclitaxel 100 mg (albumin-bound)
Form: Lyophilised powder for injectable suspension, intravenous use
Pack Size: 1 vial
Category: Anti-cancer / anti-microtubule agent
Prescription: Required (Rx)
Manufacturer / Marketer: Adley Formulations Pvt. Ltd., SCO-42, Sector 12, Panchkula – 134112, Haryana, India
Country of Origin: India
Key Benefits
Uses
Breast cancer
Non-small cell lung cancer
Ovarian cancer
AIDS-related Kaposi's sarcoma
Other uses only as decided by the treating oncologist
Technical Specifications
Directions for Use
For intravenous infusion only, prepared and administered by trained healthcare professionals.
Dose, schedule and number of cycles are set by the oncologist based on the patient's condition, body surface area and blood counts.
Do not self-administer.
Important Safety Information
Cytotoxic drug. Handle and dispose of it according to hospital cytotoxic-waste guidelines.
Common risks with paclitaxel include low blood counts (neutropenia, thrombocytopenia, anaemia), nerve-related symptoms (numbness or tingling), hair loss, fatigue, joint and muscle pain, nausea and infusion-related reactions. Regular blood count monitoring is needed.
Tell the doctor about any liver problems, existing infections, pregnancy or breastfeeding, and all other medicines being used.
Not for use in pregnancy unless the doctor decides the benefit outweighs the risk.
Albumin-bound formulations contain human albumin, a blood derivative, which carries a remote risk of viral transmission.
Albumin-bound and conventional (solvent-based) paclitaxel are not interchangeable. Do not substitute one for the other without the oncologist's instruction.
Report any serious side effects (fever, bleeding, breathing difficulty, severe rash) to a doctor immediately.
